Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
CLARITY – Safety and Efficacy of Oral Cladribine in Subjects with Relapsing-remitting Multiple Sclerosis (MS)
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
Multiple sclerosis and oligodendroglioma: an exceptional association.
ISMRM Workshop on Multiple Sclerosis as a Whole-Brain Disease
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Managing fatigue in patients with multiple sclerosis.
Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
The little compound that could: how phenytoin changed drug discovery and development.
Rituximab: Don't Count It Out as MS Treatment
Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.

Pages